About Gary P. Pisano

Professor of Business Administration, Harvard Business School


ver my three-decade career, I have explored fundamental questions about how organizations learn, innovate, and compete. A researcher, teacher and consultant to many of the world’s largest corporations, I focus on the management of innovation, strategy, enterprise growth, the commercialization of science and international competitiveness. My work on these topics has spanned a broad range of industries, including aerospace, automotive, apparel, electronics, entertainment, financial services, health care, manufacturing, restaurants, semiconductors, software, specialty chemicals and web services.

About Gary Pisano

I am the author of more than 100 scholarly publications and cases studies. My article, “Dynamic Capabilities and Strategic Management” (with David Teece and Amy Shuen, Strategic Management Journal, 1997), is one of the most highly cited papers in the fields of economics and management and was instrumental in launching a new capability-based perspective on strategy. My article, “Restoring American Competitiveness” (with Willy Shih), won the 2009 McKinsey Award for best publication in the Harvard Business Review. My forthcoming and seventh book, “Creative Construction: The DNA of Sustained Innovation,” examines how larger enterprises can leverage scale to become transformational innovators.

At Harvard Business School, I have taught both MBA and executive level courses on technology and operations management, competitive strategy, the management of innovation, product development, commercializing science and corporate growth strategies. I created and currently teach the new elective MBA course, “Managing Growth.” I am also the co-creator and co-chair of the new executive program, “Driving Profitable Growth.”

In addition to my academic research and teaching, I serve as an advisor to senior leaders at leading corporations around the world and have been a director of both public and private companies. I currently serve on the boards of directors of Axcella Health and Celixir.